These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date Terminated 2005-000292-17 A randomized study on the use of thalidomide administered either in a continually route or in cycles in association with high dose dexamethasone in patients with refractory or relapsed multiple myelom... bad-data
Completed, but no date, and reported results 2005-003083-36 Efficacy and safety of factor VIIa eptacog alfa, Novoseven on rebleeding after surgery for spontaneous supratentorial intracerebral, hemorrhage. A randomized, controlled, open-label, investigator-bl... bad-data
Completed, but no date 2005-004874-26 An open label study on the use of Velcade in combination with high-dose dexamethasone as first line therapy in multiple myeloma patients aged </= 65 years bad-data
Ongoing 2005-005913-40 A phase II, multicentre, clinical study evaluating the safety and efficacy of Treosulfan-based conditioning of allogenic transplantation of haemopoietic stem-cells in patients affected by Thalassemia ... not-yet-due
Completed, but no date Terminated 2006-000012-24 A phase II study of the safety and efficacy of doxycycline administered cyclically in patients suffering from Transthyretin Amiloidosis ATTR bad-data
Completed, but no date 2006-001462-16 A phase II Study of Bortezomib (Velcade), a proteasome Inhibitor, in treating patients with idiopathic Myelofibrosis (IM) randomized to receive new investigational drugs. bad-data
Ongoing 2006-003843-22 prospeCtive study on intensive early rheumatoid arthritis treatment with adalimUmab: induction of REmission and maintenance - 'CURE' A Phase IV multicenter, randomized, double-blind study CURE-Pro... not-yet-due
Ongoing 2006-004067-53 A multicenter randomized study on the use of rabbit anti-T-Lymphocite globulin ATG different doses to prevent GVHD in children receiving allogenic stem cell transplantation not-yet-due
Completed, but no date 2007-000468-26 A phase I/II multicentre study to evaluate the safety and efficacy of rituximab (monoclonal antibody anti-CD20) for prevention and/or therapy of EBV-disease. bad-data
Completed, but no date Terminated 2007-000564-25 Fondaparinux vs Lepirudin in the treatment of heparin-induced thrombocytopenia, with or without thrombosis. A multicenter, randomized, parallel group study of treatment with fondaparinux (7.5 mg s.c.... bad-data
Completed, but no date 2007-001347-21 A randomised clinical trial on heparin versus saline solution (NaCl 0,9%) in the maintenance of peripherical venous catheters bad-data
Completed, but no date, and reported results 2007-002519-22 Endothelial progenitor cells mobilization induced by atorvastatin in patients with chronic coronaric disease (stable angina) treated with revascularization with antibody antiCD34 covered stent bad-data
Completed, but no date 2007-003032-37 Comparative study on triamcinolone and bevacizumab efficacy in macular edema treatment and in retinic or chorioretinic neovessels treatment bad-data
Completed, but no date, and reported results 2007-004853-27 A phase IV monocentre study to evaluate palonosetron in nausea/vomiting prevention in patients with breast or colon cancer, treated with moderately aemotogenic chemotherapic agents bad-data
Completed, but no date, and reported results 2007-005045-38 Pharmacokinetic and colimicine (ColistinaR) concentrations in broncho alveolar lavage in patients affected by pulmonary infections caused by Gram - bacteria. bad-data
Completed, but no date Terminated 2007-005287-27 A Phase II Multicenter Pilot Study of the Safety and Efficacy of Doxycycline on disease progression in early to moderate ATTR amyloidosis bad-data
Completed, but no date Terminated 2007-006037-13 An open-label, phase II study of cyclophosphamide, lenalidomide and dexamethasone (CLD) for previously treated patients with AL amyloidosis bad-data
Completed, but no date Terminated 2007-007045-12 An open label, single institution, phase II study of the mTOR inhibitor temsirolimus in unresectable and/or metastatic renal cell carcinoma (RCC) in patients previously treated with both cytokines and... bad-data
Not reported Terminated 2007-007550-66 Lipidic emulsions influence on immune response of pre-term VLBW newborns treated with total parenteral nutrition 2014-03-12 due-trials
Ongoing 2008-000101-11 Multicenter, prospective, randomized clinical trial to assess two different doses of anti-human-T-lymphocyte immune serum preparation derived from rabbit in GVHD profilaxis in pediatric population wit... not-yet-due
Ongoing 2008-000102-36 Immunosoppressive protocol based on everolimus and calcineurin inhibitor low doses in lung transplant recipients with moderate-severe kidney disease after standard immnuotherapy. not-yet-due
Completed, but no date 2008-000103-29 A single arm phase 2 study on the efficacy of Pegfilgrastim (Neulasta) after DCEP chemotherapy: a feasibility study in multiple myeloma patients eligible for autologous transplant. bad-data
Completed, but no date Terminated 2008-001175-29 Phase II trial evaluating fotemustine (Muphoran) treatment in patients with refractory or relapsing multiple myeloma bad-data
Completed, but no date Terminated 2008-001462-81 Effects of Losartan versus Nebivolol versus the association of both on the progression of aortic root dilation in Marfan Syndrome (MFS) with FBN1 gene mutations bad-data
Completed, but no date 2008-001903-42 An exploratory phase II dose escalation study of eltrombopag in MYH9 related disease bad-data
Completed, but no date Terminated 2008-002273-12 Long term opioid administration in oncologic chronic pain: open label, prospective study on efficacy, safety and pharmacogenetic factors. bad-data
Not reported Terminated 2008-002292-27 Long term opioid administration in no-oncologic chronic pain: open label, prospective study on efficacy, safety and pharmacokinetic factors 2014-05-20 due-trials
Completed, but no date 2008-006559-27 Exploratory study on Omalizumab in patients affected by Painful Bladder Syndrome bad-data
Completed, but no date, and reported results 2008-006560-11 Prevention of human cytomegalovirus (HCMV) mother-to-fetus transmission by administration of virus-specific hyperimmune globulin to pregnant women with primary HCMV infection bad-data
Completed, but no date 2008-007047-13 Prevention and treatment of kidney transplantation rejection by means of innovative therapeutic apheresis. bad-data
Ongoing 2008-007086-23 Whole lung lavage followed by inhaled Sargramostim in the treatment of autoimmune pulmonary alveolar proteinosis. not-yet-due
Not reported 2009-011838-10 PHASE II STUDY ON TREATMENT WITH VELCADE, DEXAMETHASONE AND FOTEMUSTINE IN PATIENTS AFFECTED BY RELAPSED/REFRACTORY MULTIPLE MYELOMA 2013-06-28 due-trials
Completed, but no date 2009-011856-23 Evaluation of acute postsurgery pain management in patients who undergo inguen hernia surgery bad-data
Completed, but no date Terminated 2009-013484-19 Clinical trial on use of Saquinavir in patients affected by primitive glomerulonephritis associated to resistant nephrotic syndrome. bad-data
Completed, but no date Terminated 2009-017704-86 Phase II clinical trial for the Staph. Aureus spondylodiscitis treatmen with daptomycin bad-data
Completed, but no date 2010-019393-32 Evaluation of pharmacokinetics of levobupivacaine and ropivacaine during epidural infusion bad-data
Completed, but no date 2010-019829-34 AN OPEN LABEL EXTENSION STUDY TO EVALUATE THE SAFETY AND EFFICACY OF DIFLUNISAL IN TRANSTHYRETIN HEREDITARY AMYLOIDOSIS bad-data
Completed, but no date 2010-020422-17 A single center, twelve-month, open-label, prospective study followed by a six-month withdrawal period to evaluate the efficacy, tolerability, safety and pharmacokinetics (PK) of doxycycline in comb... bad-data
Completed, but no date Terminated 2010-022627-29 Innate immune responses in patients with chronic hepatitis B treated with Sebivo (telbivudine) bad-data
Ongoing 2011-001787-22 An open-label, phase II study of Pomalidomide and Dexamethasone (PDex) for previously treated patients with AL amyloidosis Studio in aperto di fase II con pomalidomide e desametasone (PDex) per paz... not-yet-due
Completed, but no date, and reported results 2011-004096-36 Efficacy of thalidomide in the treatment of severe recurrent epistaxis in hereditary hemorrhagic telangiectasia (HHT) Efficacia di talidomide nel trattamento dell'epistassi severa ricorrente nella ... bad-data
Completed, but no date Terminated 2011-005847-29 An Open Label Phase II Study on the Use of Panobinostat in Combination with Bortezomib and Dexamethasone as Induction in Multiple Myeloma Patients Candidate to High-Dose Therapy Studio di fase II s... bad-data
Ongoing 2011-006331-35 Efficacy and safety of long term local anaesthetic intralesional infusion in patients with mammary carcinoma undergoing mastectomy with breast reconstruction: a randomized, double-blind study. EFFI... not-yet-due
Not reported Terminated 2012-004796-39 A Comparative Study of Oxycodone/Naloxone versus Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Knee and/or hip Pain Due to Osteoarthritis Studio comparativo tra le due associaz... 2015-11-03 due-trials
Ongoing 2012-005265-13 Efficacy of intralesional infusion of local anesthetics in patients undergoing major abdominal surgery: a randomized double-blind trial. Efficacia dell’infusione intralesionale di anestetico loca... not-yet-due
Completed, but no date 2014-000608-90 Eltrombopag for inherited thrombocytopenias. bad-data
Completed, but no date, and reported results Terminated 2015-001189-24 Oral vs Intravenous Aspirin administration in patients with ST-elevation Myocardial Infarction undergoing primary PCI. SOmministrazione oraLE vs enDOvenosa di aspirina in pazienti con infarto mioc... bad-data
Completed, but no date Terminated 2015-003402-16 Glioma lesions outlining with optics modification assistance: a phase II trial evaluating fluorescein-aided glioblastoma surgery Identificazione delle lesioni gliali con l'aiuto di modifiche ottich... bad-data
Completed, but no date Terminated 2016-000489-50 A Phase II, Single Arm, Open Label, Efficacy and Safety Study of NEOD001 in Subjects with Light Chain (AL) Amyloidosis with Hepatic Involvement Studio di fase II, open label, a singolo braccio, tes... bad-data
Ongoing 2016-001772-30 Clinical burden of anemia in inflammatory bowel disease: Role of Iron Deficiency And iron Replacement Therapy, therapeutic trial Impatto clinico dell’anemia nelle malattie infiammatorie intestinali... not-yet-due
Not reported 2017-001621-41 A phase III randomized study of doxycycline and tauroursodeoxycholic acid (Doxy/TUDCA) plus standard supportive therapy versus standard supportive therapy alone in cardiac amyloidosis caused by transt... 2022-09-23 due-trials
Listed as ongoing, but also has a completion date 2017-002210-31 A randomized phase II/III trial of doxycycline vs. standard supportive therapy in newly-diagnosed cardiac AL amyloidosis patients undergoing bortezomib-based therapy Randomisierte Phase II/III Stud... 2022-04-14 bad-data
Ongoing 2018-000532-94 Optimal duration of dual antiplatelet therapy in patients treated by endovascular revascularization of the superficial femoral artery (Dual Antiplatelet Therapy-Superficial Femoral Artery, DAPT-SFA) ... not-yet-due
Ongoing 2019-001962-13 A multi-center open label phase II study of daratumumab and pomalidomide in previously treated patients with AL amyloidosis Studio di fase II, multicentrico, in aperto, volto a valutare l’associazi... not-yet-due
Exempt 2019-003362-41 Phase I/IIa clinical trial on the safety and preliminary efficacy of donor-derived anti-leukemia cytotoxic T lymphocytes for the prevention of leukemia relapse in children given haploidentical hematop... not-yet-due
Completed, but no date, and reported results Terminated 2020-001185-11 A proof-of concept study of the use of Janus Kinase 1 and 2 Inhibitor, Baricitinib, in the treatment of COVID-19-related pneumonia: a two-step phase II clinical trial Baricitinib per la polmonite d... bad-data
Not reported 2020-003505-58 A proof-of-concept study of the use of Inhaled liposomal -Cyclosporin-A in the treatment of moderate COVID-19-related pneumonia: a two-step phase II clinical trial 2022-06-30 due-trials
Ongoing 2021-001203-32 An open-label, multi-center, phase 2 study of chemo-immunotherapy followed by reduced-dose hypo-fractionated RT and maintenance immunotherapy for stage III unresectable Non –small-cell lung carcinoma ... not-yet-due
Exempt 2021-004755-17 PHASE I/II CLINICAL TRIAL OF ALLOGENEIC BONE MARROW DERIVED MESENCHYMAL STROMAL CELL THERAPY FOR THE PREVENTION AND TREATMENT OF PULMONARY FIBROSIS SECONDARY TO POST-INFECTIVE ARDS OR ALLOIMMUNE REACT... not-yet-due